Cargando…
The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer
High-risk human papillomavirus (HPV) persistent infection is the major tumorigenesis factor for cervical cancer (CC). However, the incidence of HPV-negative CC is 5% to 30% with different HPV detection methods. High-risk HPV E6/E7 mRNA in situ hybridization (RISH) can detect HPV-driven tumors. Our s...
Autores principales: | Xu, Yating, Sun, Yonghong, Chang, Hui, Cai, Jingjing, Cao, Chengcheng, Zhang, Baogang, Zhang, Youzhong, Liu, Yuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741987/ https://www.ncbi.nlm.nih.gov/pubmed/35443260 http://dx.doi.org/10.1097/PGP.0000000000000870 |
Ejemplares similares
-
HPV-negative Tumors in a Swedish Cohort of Cervical Cancer
por: Kaliff, Malin, et al.
Publicado: (2020) -
Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions
por: Hui, Chang, et al.
Publicado: (2021) -
Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia
por: Fitzpatrick, John M, et al.
Publicado: (2012) -
Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2016) -
Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer
por: Kortekaas, Kim E., et al.
Publicado: (2020)